These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Lymphocyte membrane markers in lympho and immunoproliferative diseases (proceedings)]. Del Giacco GS; Manconi PE; Fadda F; Grifoni V; Tognella S; Mantovani G; Leone AL Minerva Med; 1977 Oct; 68(50):3433-40. PubMed ID: 927718 [No Abstract] [Full Text] [Related]
9. Immunological properties of lymphoblasts and lymphocytes in children with acute lymphatic or undifferentiated leukemia. Winterleitner H; Rella W; Eibl M; Krepler P Oncology; 1978; 35(6):258-62. PubMed ID: 284270 [TBL] [Abstract][Full Text] [Related]
10. HL-A antigens in haematological malignant diseases. Jeannet M; Magnin C Eur J Clin Invest; 1971 Nov; 2(1):39-42. PubMed ID: 5290218 [No Abstract] [Full Text] [Related]
11. [Use of antilymphocyte globulin as a study method in the identification of lymphoid antigens expressed by populations of leukemic and/or lymphomatous cells]. Marmont A Minerva Med; 1978 Apr; 69(18):1263-74. PubMed ID: 351459 [No Abstract] [Full Text] [Related]
12. The expression of a human B-lymphocyte antigen on cells in different types of leukaemia. Turesson I; Berntorp E; Zettervall O Acta Med Scand; 1979; 206(1-2):31-6. PubMed ID: 90448 [No Abstract] [Full Text] [Related]
13. HL-A antigens and susceptibility to malignant hematological diseases. Richter KV; Fischer G; Menzel GR; Langfeld M; Aigte H; Rückwarth G; Freier G Haematologia (Budap); 1973; 7(2):203-9. PubMed ID: 4524911 [No Abstract] [Full Text] [Related]
14. [Spontaneous autorosette formation indices in acute leukemia]. Mazurenko VA Vrach Delo; 1981 Jul; (7):42-6. PubMed ID: 6974430 [No Abstract] [Full Text] [Related]
15. [Immunological evaluation of FAB classification of acute leukemia]. Takiguchi T; Konda S Rinsho Ketsueki; 1982 Jul; 23(7):1030-6. PubMed ID: 6958887 [No Abstract] [Full Text] [Related]
16. [Surface markers of the blast cells in various forms of acute leukemia]. Korotkiĭ VV; Loginskiĭ VE; Vygovskaia IaI; Mazurok AA; Kotsaĭ BR Ter Arkh; 1978; 50(7):22-6. PubMed ID: 309666 [No Abstract] [Full Text] [Related]
17. Enzymes of purine metabolism and membrane phenotype in malignant cells of some leukemia patients. Babusíková O; Hrivnáková A; Pechán I; Ujházy P Neoplasma; 1984; 31(6):661-6. PubMed ID: 6441124 [TBL] [Abstract][Full Text] [Related]
18. [Cellular immunity indices in acute leukemia in a period of remission]. Miterev GIu; Samoĭlova RS; Bulycheva TI; Kovaleva LG; Maiakova SA Probl Gematol Pereliv Krovi; 1979 Jan; 24(1):28-34. PubMed ID: 311002 [No Abstract] [Full Text] [Related]
20. In vitro activation of lymphocytes from patients with malignant diseases. I. Kinetics and differences in magnitude of response. Benezra D; Hochman A Isr J Med Sci; 1971 Apr; 7(4):553-60. PubMed ID: 5281061 [No Abstract] [Full Text] [Related] [Next] [New Search]